Topup TG. Fuiyoh lucky i reserve my bullet.

bro ur intuition is quite accurate , lets follow ur moves.

Of course not. Otherwise, I would have re-mortgaged my house and sai lang everything into glove stocks. 

But what have I got to lose? Maybe lose back all the profits that I made last week when the four 2nd liner stocks that I bought limit up? It's OK. I can accept that. 

WASHINGTON, Aug 25 — Dr Stephen Hahn, the commissioner of the US Food and Drug Administration, apologised yesterday after misrepresenting a key statistic on how effective blood plasma is for treating Covid-19 when announcing an emergency approval measure.

The US on Sunday issued emergency approval for plasma taken from recovered coronavirus patients, so that more people can get access to the experimental treatment.

But Hahn and other senior health officials came under fire from experts after repeating a claim made by President Donald Trump that blood plasma from recovered Covid-19 patients reduced mortality rates by 35 per cent.

“What that means is — and if the data continue to pan out — 100 people who are sick with Covid-19, 35 would have been saved because of the administration of plasma,” Hahn said Sunday, after Trump had called it “a tremendous number.”

Health secretary Alex Azar added: “I just want to emphasise this point, because I don't want you to gloss over this number. We dream in drug development of something like a 35 per cent mortality reduction. This is a major advance in the treatment of patients. This is a major advance.”

Such a reduction would indeed be a game changer in the fight against the pandemic — but the statistic is false.

The officials said these results came from a study of 35,000 patients conducted by Mayo Clinic, but Dr Scott Wright, the study's leader, told AFP it did not come from his institution's research. He said he believed it might be an “integrated analysis” the FDA had arrived at by looking at both Mayo's work and other studies.

FDA spokeswoman Emily Miller later tweeted that 35 per cent referred to the relative difference in mortality risk between those patients in Mayo's study who received a high level of antibodies against those who received a low level of antibodies.

“I have been criticised for remarks I made Sunday night about the benefits of convalescent plasma,” said Hahn in a tweet thread last night. “The criticism is entirely justified. What I should have said better is that the data show a relative risk reduction not an absolute risk reduction.”

But it was not immediately clear which figures the FDA had used from the Mayo study to arrive even at this far more modest claim. The study has not yet been peer-reviewed and is available in “preprint” form on a medical research server, so it remains possible that more data will eventually be forthcoming.

The scientific community is divided on whether plasma should have received an emergency use approval.

Early research suggests it may be helpful and safe but no clinical trials — considered the gold standard of medical research — have yet found conclusively in its favour.

Political commentators have questioned the timing of the FDA's latest move as Trump lags in polls before the November election. — AFP

Kossan result out

PAT 131m

Guys, update on kossan.

Profit 131m
Profit to meet market expectations of PE 25 = 243.5m

Underexpectation by 46%, another harta

Btw, both kossan and harta already formed Head and shoulder formation

IMO that would be the bad timing to get the TG on the first day of split, for us existing "investors" that's it

first day sure got a lot of people will goreng, imagine TG price is less than RM10, making it a lot more affordable for most to "invest"
and those gotten the bonus shares will dispose it at a higher price for a quick profit

I'm going with my guts this time, got a gut feeling the price gonna hit RM15 within a week after the split, if there are no more bad news/rumors along the way

anyway, i'm still a noob in this, just hope my instinct is correct and gonna grab some TG tomorrow when it drop further

Wow, bro u trade without knowing simple technical patterns, U r fcking legendary momentum trader

NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES KOSSAN RUBBER INDUSTRIES BHD (KOSSAN OR COMPANY) PROPOSED BONUS ISSUE OF 1,278,935,808 NEW ORDINARY SHARES IN KOSSAN ("KOSSAN SHARES" OR "SHARES") ("BONUS SHARES") ON THE BASIS OF 1 BONUS SHARE FOR EACH EXISTING KOSSAN SHARE HELD ON AN ENTITLEMENT DATE TO BE DETERMINED LATER ("PROPOSED BONUS ISSUE")

i dun think so.

kossan PAT 131 mil exceeds some analysts expectations:
and bonus plan now...

tmr, kossan may not bounce back big but shud recover a bit.

of course, naysayers will say it's dead la, like all gloves... which one r u?!

If tg director buying at 24 suppose pat will above 600m

that is true... they want limit up EVERYDAY... spoiled rotten... 20 yr olds, 70 yr olds.
and next.... TG on sep17 ... they expect big big results.

the wanna see 2bil PAT for ONE QUARTER... so that they see... limit up!

1.4 is possible, though... i will take that.

to all the pharma fans, it may interest u to do this exercise...

will the pharma counters fly, limit up, etc...?

just check the stock prices of the real cos. that are working on the vaccines, not bottling and sell for a profit from a fat contract.

astrazeneca, j&j, pfizer, cansino, etc... even gilead... the famous DT promoted remdesivir.

most are flat or going down. i m not touching the "limit up pharma counters" in bursa.

this fella called covid19 isn't a toy for politicians or cronies to use to promote their own agenda!

https://www.forbes.com/sites/moneyshow/2020...e/#5192a22976ad
https://www.google.com.my/search?biw=1745&b...Q4dUDCA0&uact=5

:thumbsup:
Thanks. I didn't know about this. Let's see how Kossan will perform tomorrow and this week.

If we follow the trend of Harta, Top Glove and Supermax after the release of strong QR, Kossan will fall tomorrow.   

I am hoping Kossan will buck the trend and rise instead.

Get out of all gloves. Don’t wait until earnings except TopGlove. All in secondary gloves and TopGlove.

Better observe first before proceed to re entry for tmr for big 4. Might be another pharma day

Pharma news more and more.

https://www.abc.net.au/news/2020-08-26/uq-c...msters/12594726

Better to have a look first for top up